Evaluation of the commercially available LightMix® Modular E-gene kit using clinical and proficiency testing specimens for SARS-CoV-2 detection
Detection Principle
NucleicAcid-PCR based
Target
E gene
Testing Method Category
RT-PCR
Testing Method
LightMix Modular SARS and Wuhan CoV E-gene kit
Testing Method - Additional Info
Comparison of the novel kit against the well-validated in house methods
Reported Performance
LOD: 1.8 × 10?1 TCID50/mL; Sensitivity 51,6%;
Sample Size
289 patients
Peer-reviewed
yes
The database contains available information from scientific literature that is being updated periodically. Please note that the provided information (as retrieved from analysed papers) is provided only for devices commercially available with CE-IVD mark. Acknowledgements